Synonyms
Antibiotic resistance
Definition
β-lactam resistance refers to the intrinsic or acquired ability of bacteria to avoid the action of β-lactam antibiotics. It is important to note that resistance in the clinical setting may not be predictable by in vitro susceptibility testing. In some cases, susceptible bacteria may be located in areas that are not accessible to antibiotics, or the presence of biofilms may restrict antibiotic access to susceptible strains, so strains may behave as if they are resistant. Thus, when using an antimicrobial agent, the in vitro susceptibility and metabolic state of the bacterial strain, as well as the attainable drug concentrations at the infection site, must also be considered.
Introduction
β-lactam antibiotics are one of the oldest and most prescribed classes of antibacterial treatments worldwide (Hamad 2010). They comprise a class of natural, synthetic, and semisynthetic compounds that act by inactivating enzymes involved in cell wall synthesis....
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ambler RP, Coulson AF, Frere JM, Ghuysen JM, Joris B, Forsman M, et al. A standard numbering scheme for the class A beta-lactamases. Biochem J. 1991;276(Pt 1):269–70.
Bebrone C. Metallo-beta-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily. Biochem Pharmacol. 2007;74(12):1686–701.
Bush K, Jacoby GA. Updated functional classification of beta-lactamases. Antimicrob Agents Chemother. 2010;54(3):969–76.
Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 1995;39(6):1211–33.
Chen Y, McReynolds A, Shoichet BK. Re-examining the role of Lys67 in class C beta-lactamase catalysis. Protein Sci. 2009;18(3):662–9.
Davin-Regli A, Bolla JM, James CE, Lavigne JP, Chevalier J, Garnotel E, et al. Membrane permeability and regulation of drug “influx and efflux” in enterobacterial pathogens. Curr Drug Targets. 2008;9(9):750–9.
Hamad B. The antibiotics market. Nat Rev Drug Discov. 2010;9(9):675–6.
Helfand MS, Bonomo RA. Beta-lactamases: a survey of protein diversity. Curr Drug Targets Infect Disord. 2003;3(1):9–23.
Jacoby GA. Amp C beta-lactamases. Clin Microbiol Rev. 2009;22(1):161–82.
Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria. Drugs. 2004;64(2):159–204.
Liang Z, Li L, Wang Y, Chen L, Kong X, Hong Y, et al. Molecular basis of NDM-1, a new antibiotic resistance determinant. PLoS ONE. 2011;6(8):e23606.
Livermore DM, Woodford N. The beta-lactamase threat in Enterobacteriaceae. Pseudomonas and Acinetobacter. Trends Microbiol. 2006;14(9):413–20.
Majiduddin FK, Materon IC, Palzkill TG. Molecular analysis of beta-lactamase structure and function. Int J Med Microbiol. 2002;292(2):127–37.
Maveyraud L, Golemi-Kotra D, Ishiwata A, Meroueh O, Mobashery S, Samama JP. High-resolution X-ray structure of an acyl-enzyme species for the class D OXA-10 beta-lactamase. J Am Chem Soc. 2002;124(11):2461–5.
Morell EA, Balkin DM. Methicillin-resistant Staphylococcus aureus: a pervasive pathogen highlights the need for new antimicrobial development. Yale J Biol Med. 2010;83(4):223–33.
Murray P, Rosenthal KS, Pfaller MA. Medical microbiology. 5th ed. Philadelphia: Elsevier Mosby; 2005.
Naas T, Oxacelay C, Nordmann P. Identification of CTX-M-type extended-spectrum-beta-lactamase genes using real-time PCR and pyrosequencing. Antimicrob Agents Chemother. 2007;51(1):223–30.
Pages JM, James CE, Winterhalter M. The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nat Rev Microbiol. 2008;6(12):893–903.
Poole K. Resistance to beta-lactam antibiotics. Cell Mol Life Sci. 2004;61(17):2200–23.
Rice LB. Mechanisms of resistance and clinical relevance of resistance to beta-lactams, glycopeptides, and fluoroquinolones. Mayo Clin Proc. 2012;87(2):198–208.
Tzouvelekis LS, Bonomo RA. SHV-type beta-lactamases. Curr Pharm Des. 1999;5(11):847–64.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this entry
Cite this entry
Cardenas, A.M., Palzkill, T. (2015). Beta-Lactam Resistance. In: Highlander, S.K., Rodriguez-Valera, F., White, B.A. (eds) Encyclopedia of Metagenomics. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7475-4_58
Download citation
DOI: https://doi.org/10.1007/978-1-4899-7475-4_58
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-7474-7
Online ISBN: 978-1-4899-7475-4
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences